Cafepharma Today

January 17 2025 - Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy
Novo Nordisk touts 'superior' weight loss results in study of high-dose Wegovy
AstraZeneca overhauls management of its scandal-hit China division
Lykos still plotting path to approval for rejected MDMA therapy after 'productive' FDA meeting
Ozempic tops new Medicare price negotiation list
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Biotech Outlook: M&A to Continue
Zacks.com
Tuesday, September 2, 2008 - 8:54am
tags:
Mylan's Alphapharm wins patent litigation on generic Razadyne tablets
Pharmaceutical Business Review
Tuesday, September 2, 2008 - 8:50am
tags:
Study: Drug sales may not benefit from ads directed to patients
USA Today
Tuesday, September 2, 2008 - 8:50am
tags:
China's Hepatitis B Market to Double by 2012
Seeking Alpha
Monday, September 1, 2008 - 11:33am
tags:
Glaxo Loses Preemption Ruling In Paxil Suicide
Pharmalot
Monday, September 1, 2008 - 11:32am
tags:
Shionogi to Buy Sciele Pharma to Get U.S. Sales Staff
Bloomberg
Monday, September 1, 2008 - 11:29am
tags:
Is a Hurricane Lurking for Merck and Schering-Plough?
Seeking Alpha
Sunday, August 31, 2008 - 10:53am
tags:
Ranbaxy emerges as top pharma company (in India) in July
Smart Money, India
Sunday, August 31, 2008 - 10:30am
tags:
Prasugrel Head-to-Head Study Showed Reduced Cardiovascular Events in Diabetes Patients by 30 Percent Compared with Clopidogrel
CNN Money
Sunday, August 31, 2008 - 10:26am
tags:
Bayer's Xarelto Test Program Moves Ahead Faster Than Planned
Smart Money
Sunday, August 31, 2008 - 10:24am
tags:
The Contrarian Case For Pfizer
Investopedia
Saturday, August 30, 2008 - 10:35am
tags:
Cholesterol drugs' cancer risk in spotlight
Yahoo
Saturday, August 30, 2008 - 10:34am
tags:
Generics Face Uphill Battle
Forbes
Saturday, August 30, 2008 - 10:33am
tags:
Stent Makers Getting Desperate
Motley Fool
Saturday, August 30, 2008 - 10:33am
tags:
Court sides with Pfizer over Lipitor ingredient patents
Bizjournals
Saturday, August 30, 2008 - 10:32am
tags:
BDSI shares jump for 2nd straight day after Onsolis news
Bizjournals
Saturday, August 30, 2008 - 10:28am
tags:
Cambrex Corporation Q2 2008 Earnings Call Transcript
Seeking Alpha
Saturday, August 30, 2008 - 10:26am
tags:
Health Winners & Losers: Pfizer
Yahoo/The Street
Saturday, August 30, 2008 - 10:25am
tags:
Technical Outlook: Bullish on Biotech
Yahoo/The Street
Saturday, August 30, 2008 - 10:25am
tags:
BioSyent Releases Financial Results-Second Quarter 2008
Genetic Engineering News
Saturday, August 30, 2008 - 10:22am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

2025 Brand Drug Challenges: A GoodRx Perspective
Drug Channels
Snake Antivenoms, Computed
In the Pipeline
Versatile Chaperones
In the Pipeline
Dealing With Being a Tumor Cell
In the Pipeline
Why 340B Reform Could Happen in 2025 (video)
Drug Channels
Drug Channels Leadership Forum: Request an Invitation Before It’s Too Late!
Drug Channels
The Pain Comes With the Territory
In the Pipeline
A New Antiviral Target, On the Host Side
In the Pipeline
Inside a Fentanyl Kitchen
In the Pipeline

Latest Jobs

Account Executive
McAlester, Oklahoma, 74502
Elara Caring
Account Executive
San Antonio, Texas, 78284
Elara Caring
Account Executive
Wichita Falls, Texas, 76309
Elara Caring
Account Executive
Dallas, Texas, 75219
Elara Caring
Account Executive, Home Health
Austin, Texas, 78703
AccentCare, Inc.
Account Executive
Monroe, Louisiana, 71201
Elara Caring
Account Executive
Clinton Township, Michigan, 48036
Elara Caring
Sales Representative- Wilmington/Harrisburg- Communications
Lancaster, Pennsylvania, 17699
Stryker
Sales Representative- Southern MD- Communications
Washington, District of Columbia, 20080
Stryker
Account Executive, Home Health
Temple, Texas, 76504
AccentCare, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information